4.22.21 | Coronavirus
COVID-19 Impedes Career Progress for Women in STEMM
The COVID-19 pandemic has imperiled the careers of many women in the biomedical workforce as they face disproportionately greater caregiving responsibilities at home and related productivity losses at work.
4.19.21 | Bone Health
Report on Osteoporosis-Related Bone Fractures Reveals High Burden on Women and Society
Implementing broader efforts around the prevention of osteoporosis and treatment of related fractures would have a major impact on women’s quality of life.
4.13.21 | Coronavirus
COVID-19: More Research Needed on Maternal and Infant Health Outcomes
Pregnant individuals and newborns have immune systems that are more susceptible to viral infections than the general population.
4.7.21 | Research and Clinical Trials
Panel: Improving Diversity in Clinical Trials Better Serves Patients
Researchers and health care stakeholders must actively pursue more representative clinical trials and make changes that encourage the participation of historically marginalized groups within the research community.
3.30.21 | Policy
Exploring Opportunities to Engage with NIH and FDA to Advance Research
SWHR looks forward to working with the new Congress and administration to advance women’s health, and will continue to support robust funding for the NIH to benefit research that addresses the unique health needs of women across the lifespan.
3.22.21 | Endometriosis
SWHR’s Endometriosis Toolkit Empowers Patients to Take Charge of Their Health
SWHR launched its new Endometriosis Toolkit: A Guide to Patient Empowerment, designed to help people of all ages with endometriosis navigate their care.
3.19.21 | Uterine Fibroids
SWHR Supports Bill to Improve Fibroids Education and Research Funding
SWHR endorses the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, designed to improve funding for research and increase education about fibroids.
3.18.21 | Coronavirus
Long COVID: The Impact on Women and Ongoing Research
As the end of the COVID-19 pandemic seems in sight, we are still far from fully understanding the virus and its long-term impact.
3.9.21 | Research and Clinical Trials
People of Color Continue to Be Underrepresented in Research on New Drugs
After decades of being underrepresented in biomedical research, women have accounted for more than 50% of participants in clinical trials for FDA-approved new drugs in the past four years.
3.4.21 | Health Equity
Harnessing the Power of AI for All Patients Requires Focus on Equity and Transparency
It is imperative that AI developers and regulators consider race, ethnicity, and gender in their datasets to work toward improved health equity for women and people of color.
